Skip to content

Advertisement

BMC Urology

What do you think about BMC? Take part in

Urological oncology

Section edited by Philippe Spiess, Jose Karam and Chris Protzel

This section considers clinical studies relevant to oncological disorders in urology

Previous Page Page 1 of 8 Next Page
  1. Content type: Research article

    This study compared the detection rates for clinically significant prostate cancer (CSPC) between magnetic resonance imaging and ultrasonography (MRI/US)-fusion-targeted biopsy (TB), systematic biopsy (SB) and...

    Authors: Yuji Hakozaki, Hisashi Matsushima, Jimpei Kumagai, Taro Murata, Tomoko Masuda, Yoko Hirai, Mai Oda, Nobuo Kawauchi, Munehiro Yokoyama and Yukio Homma

    Citation: BMC Urology 2017 17:117

    Published on:

  2. Content type: Research article

    Clear cell renal cell carcinoma (ccRCC) is the third most common urological cancer in adults. Our aim is to evaluate genes and miRNAs expression profiles involved with angiogenesis and tumor characteristics in...

    Authors: Rita de Cássia Oliveira, Renato Fidelis Ivanovic, Katia Ramos Moreira Leite, Nayara Izabel Viana, Ruan César Aparecido Pimenta, José Pontes Junior, Vanessa Ribeiro Guimarães, Denis Reis Morais, Daniel Kanda Abe, Adriano João Nesrallah, Miguel Srougi, William Nahas and Sabrina Thalita Reis

    Citation: BMC Urology 2017 17:113

    Published on:

  3. Content type: Research article

    Recently, the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26) was recommended for the assessment of adverse effects after the treatment of prostate cancer without clear reasons. This decisio...

    Authors: Karol Axcrona, Rasmus Nilsson, Bjørn Brennhovd, Øystein Sørebø, Sophie D. Fosså and Alv A. Dahl

    Citation: BMC Urology 2017 17:111

    Published on:

  4. Content type: Research article

    The purposes of this study were to determine whether adjuvant chemotherapy (AC) improved the prognosis of patients with high-risk upper urinary tract urothelial carcinoma (UTUC)and to identify the patients who...

    Authors: Kazutoshi Fujita, Kei Taneishi, Teruo Inamoto, Yu Ishizuya, Shingo Takada, Masao Tsujihata, Go Tanigawa, Noriko Minato, Shigeaki Nakazawa, Tsuyoshi Takada, Toshichika Iwanishi, Motohide Uemura, Yasushi Okuno, Haruhito Azuma and Nonomura Norio

    Citation: BMC Urology 2017 17:110

    Published on:

  5. Content type: Research article

    In prostate cancer, men diagnosed with low risk disease may be monitored through an active surveillance. This research explored the perspectives of men with prostate cancer regarding their decision-making proc...

    Authors: Margaret Fitch, Kittie Pang, Veronique Ouellet, Carmen Loiselle, Shabbir Alibhai, Simone Chevalier, Darrel E. Drachenberg, Antonio Finelli, Jean-Baptiste Lattouf, Simon Sutcliffe, Alan So, Simon Tanguay, Fred Saad and Anne-Marie Mes-Masson

    Citation: BMC Urology 2017 17:98

    Published on:

  6. Content type: Research article

    Multi-step testing might enhance performance of the prostate cancer diagnostic pipeline. Using PSA >1 ng/ml for first-line risk stratification and the Stockholm 3 Model (S3M) blood-test >10% risk of Gleason Sc...

    Authors: Tobias Nordström, Jan Adolfsson, Henrik Grönberg and Martin Eklund

    Citation: BMC Urology 2017 17:92

    Published on:

  7. Content type: Research article

    Positive surgical margins are a strong prognostic marker of disease outcome following radical prostatectomy, though prior evidence is largely from a PSA-screened population. We therefore aim to evaluate the bi...

    Authors: Ashwin Sachdeva, Rajan Veeratterapillay, Antonia Voysey, Katherine Kelly, Mark I. Johnson, Jonathan Aning and Naeem A. Soomro

    Citation: BMC Urology 2017 17:91

    Published on:

  8. Content type: Research article

    Besides clinical stage and Gleason score, risk-stratification of prostate cancer in the pretherapeutic setting mainly relies on the serum PSA level. Yet, this is associated with many uncertainties. With regard...

    Authors: Thomas Stefan Worst, Frank Waldbillig, Abdallah Abdelhadi, Cleo-Aron Weis, Maria Gottschalt, Annette Steidler, Jost von Hardenberg, Maurice Stephan Michel and Philipp Erben

    Citation: BMC Urology 2017 17:86

    Published on:

  9. Content type: Research article

    Recently, sarcopenia has been reported as a new predictor for patient outcomes or likelihood of post-operative complications. The purpose of this study was to evaluate the association of the psoas muscle volum...

    Authors: Yoko Saitoh-Maeda, Takashi Kawahara, Yasuhide Miyoshi, Sohgo Tsutsumi, Daiji Takamoto, Kota Shimokihara, Yuutaro Hayashi, Taku Mochizuki, Mari Ohtaka, Manami Nakamura, Yusuke Hattori, Jun-ichi Teranishi, Yasushi Yumura, Kimito Osaka, Hiroki Ito, Kazuhide Makiyama…

    Citation: BMC Urology 2017 17:87

    Published on:

  10. Content type: Research article

    Radical cystectomy (RC) with pelvic lymph node dissection (PLND) and urinary diversion (UD) is considered the standard treatment for muscle invasive bladder cancer (MIBC). In a part of patients, RC procedure i...

    Authors: Qing Zhang, Shiwei Zhang, Shun Zhang, Wei Wang, Xiaozhi Zhao, Yongming Deng, Huibo Lian and Hongqian Guo

    Citation: BMC Urology 2017 17:81

    Published on:

  11. Content type: Case report

    Extranodal natural killer/T-cell lymphoma (ENKTL) usually presents as a localized disease in the nasal cavity; extension to the male genitourinary system is very rare and has been characterized only recently. ...

    Authors: Xiaotian Wang, Zimu Gong, Shawn Xiang Li, Wei Yan and Yongsheng Song

    Citation: BMC Urology 2017 17:77

    Published on:

  12. Content type: Research article

    Sunitinib has become mainstay first line treatment for patients with metastatic renal clear cell carcinoma (mRCC). Still, useful predictive markers of response are lacking and urgently needed for clinical deci...

    Authors: Martin Pilskog, Christian Beisland, Lars A. Akslen, Leif Bostad, Åse Haug, Daniel Heinrich, Karin M. Hjelle and Oddbjørn Straume

    Citation: BMC Urology 2017 17:74

    Published on:

  13. Content type: Research article

    The aim of this retrospective study was to evaluate the clinical outcomes of reduced dose, biweekly docetaxel chemotherapy for Korean patients with castrate-resistant prostate cancer (CRPC).

    Authors: Hae Su Kim, Ji Yun Lee, Su Jin Lee, Ho Yeong Lim, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han-Yong Choi and Se Hoon Park

    Citation: BMC Urology 2017 17:63

    Published on:

  14. Content type: Research article

    The aim of this study was to evaluate the combined use of the overactive bladder symptom score (OABSS) and International Prostate Symptom Score (IPSS) as an assessment tool for urinary symptom flare after iodi...

    Authors: Makito Miyake, Nobumichi Tanaka, Isao Asakawa, Shunta Hori, Yosuke Morizawa, Yoshihiro Tatsumi, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Masatoshi Hasegawa, Tomomi Fujii, Noboru Konishi and Kiyohide Fujimoto

    Citation: BMC Urology 2017 17:62

    Published on:

  15. Content type: Research article

    Our aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT).

    Authors: Daniel N. Cagney, Mary Dunne, Carmel O’Shea, Marie Finn, Emma Noone, Martina Sheehan, Lesley McDonagh, Lydia O’Sullivan, Pierre Thirion and John Armstrong

    Citation: BMC Urology 2017 17:60

    Published on:

  16. Content type: Research article

    To evaluate the role of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound (mpMRI-TRUS) fusion in Chinese men with repeated biopsy.

    Authors: Huibo Lian, Junlong Zhuang, Wei Wang, Bing Zhang, Jiong Shi, Danyan Li, Yao Fu, Xuping Jiang, Weimin Zhou and Hongqian Guo

    Citation: BMC Urology 2017 17:52

    Published on:

  17. Content type: Research article

    To assess whether hemorrhagic complications associated with transperineal prostate biopsy increased in patients on antiplatelet and/or anticoagulant therapy.

    Authors: Kimitoshi Saito, Satoshi Washino, Yuhki Nakamura, Tsuzumi Konishi, Masashi Ohshima, Yoshiaki Arai and Tomoaki Miyagawa

    Citation: BMC Urology 2017 17:53

    Published on:

  18. Content type: Research article

    The neutrophil-to-lymphocyte ratio (NLR) is reported as a biomarker for some solid malignant diseases. Thus far, however, no reports of the relationship between the NLR and adrenal tumors have been published. ...

    Authors: Taku Mochizuki, Takashi Kawahara, Daiji Takamoto, Kazuhide Makiyama, Yusuke Hattori, Jun-ichi Teranishi, Yasuhide Miyoshi, Yasushi Yumura, Masahiro Yao and Hiroji Uemura

    Citation: BMC Urology 2017 17:49

    Published on:

  19. Content type: Research article

    Many urologic surgeons refer to biopsy core details for decision making in cases of localized prostate cancer (PCa) to determine whether an extended resection and/or lymph node dissection should be performed. ...

    Authors: Masahiro Yashi, Akinori Nukui, Yuumi Tokura, Kohei Takei, Issei Suzuki, Kazumasa Sakamoto, Hideo Yuki, Tsunehito Kambara, Hironori Betsunoh, Hideyuki Abe, Yoshitatsu Fukabori, Yoshimasa Nakazato, Yasushi Kaji and Takao Kamai

    Citation: BMC Urology 2017 17:47

    Published on:

Previous Page Page 1 of 8 Next Page

2016 Journal Metrics

Advertisement